Bank of New York Mellon Corp - SUTRO BIOPHARMA INC ownership

SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 140 filers reported holding SUTRO BIOPHARMA INC in Q1 2021. The put-call ratio across all filers is 0.23 and the average weighting 0.3%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of SUTRO BIOPHARMA INC
ValueSharesWeighting
Q3 2023$907,235
-22.8%
261,451
+3.4%
0.00%
Q2 2023$1,175,605
+5.9%
252,818
+5.2%
0.00%
Q1 2023$1,109,927
-42.5%
240,244
+0.6%
0.00%
Q4 2022$1,928,736
+123.0%
238,705
+53.1%
0.00%
Q3 2022$865,000
+21.1%
155,873
+13.8%
0.00%
Q2 2022$714,000
-42.3%
136,983
-9.1%
0.00%
Q1 2022$1,238,000
-44.4%
150,618
+0.7%
0.00%
Q4 2021$2,226,000
-29.4%
149,615
-10.3%
0.00%
-100.0%
Q3 2021$3,153,000
+10.4%
166,879
+8.6%
0.00%0.0%
Q2 2021$2,856,000
+23.7%
153,596
+51.5%
0.00%
Q1 2021$2,308,000
+5.4%
101,398
+0.6%
0.00%
Q4 2020$2,189,000
+254.8%
100,815
+64.3%
0.00%
Q3 2020$617,000
+59.4%
61,363
+23.0%
0.00%
Q2 2020$387,000
+31.2%
49,905
+73.0%
0.00%
Q1 2020$295,000
-6.9%
28,854
+0.1%
0.00%
Q4 2019$317,000
+21.0%
28,8380.0%0.00%
Q3 2019$262,000
-24.5%
28,838
-5.4%
0.00%
Q2 2019$347,000
+105.3%
30,472
+104.8%
0.00%
Q1 2019$169,00014,8810.00%
Other shareholders
SUTRO BIOPHARMA INC shareholders Q1 2021
NameSharesValueWeighting ↓
SV Health Investors, LLC 1,824,542$34,466,00016.86%
Samsara BioCapital, LLC 1,675,579$31,652,0004.97%
First Light Asset Management, LLC 2,191,439$41,396,0002.73%
FRAZIER MANAGEMENT LLC 1,468,663$27,743,0002.22%
AJU IB Investment Co., Ltd. 175,000$3,306,0002.13%
Opaleye Management Inc. 537,800$10,159,0001.90%
Parkman Healthcare Partners LLC 163,389$3,086,0000.78%
SUVRETTA CAPITAL MANAGEMENT, LLC 2,233,695$42,194,0000.71%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 139,331$2,629,0000.63%
BVF INC/IL 826,825$15,619,0000.61%
View complete list of SUTRO BIOPHARMA INC shareholders